ResearcherUniversitätsmedizin GöttingenActive in the last 2 years
Laura Urbach
Matched on ORCID iD 0000-0002-8034-3120; OpenAlex author ID A5003095641. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 30
2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: none · 2025: 2 papers
Papers 6
- Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. Co-author DOI 10.1038/s41467-024-55330-7↗
- TP53 missense-specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer. Co-author DOI 10.1126/sciadv.adu2339↗
- RBFOX2: a key factor in suppressing PDAC metastasis through regulation of alternative splicing events. Co-author DOI 10.1038/s41392-023-01585-3↗
- Neutrophil-derived complement factor P induces cytotoxicity in basal-like cells via caspase 3/7 activation in pancreatic cancer Co-author DOI 10.1101/2023.10.28.564512↗
- TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancer. Co-author DOI 10.1038/s43018-021-00258-w↗
- EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of GATA6. Co-author DOI 10.1158/0008-5472.can-20-0672↗
Closest collaborators
The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shiv K. Singh · 6 shared papers, 2020–2025 · strength 1.12
- Paper RBFOX2: a key factor in suppressing PDAC metastasis through regulation of alternative splicing events. DOI 10.1038/s41392-023-01585-3↗
- Paper TP53 missense-specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer. DOI 10.1126/sciadv.adu2339↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Volker Ellenrieder · 5 shared papers, 2020–2025 · strength 0.73
- Paper TP53 missense-specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer. DOI 10.1126/sciadv.adu2339↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper Neutrophil-derived complement factor P induces cytotoxicity in basal-like cells via caspase 3/7 activation in pancreati… DOI 10.1101/2023.10.28.564512↗
- Lukas Klein · 4 shared papers, 2021–2025 · strength 0.64
- Paper TP53 missense-specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer. DOI 10.1126/sciadv.adu2339↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper Neutrophil-derived complement factor P induces cytotoxicity in basal-like cells via caspase 3/7 activation in pancreati… DOI 10.1101/2023.10.28.564512↗
- Elisabeth Heßmann · 4 shared papers, 2020–2025 · strength 0.58
- Paper TP53 missense-specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer. DOI 10.1126/sciadv.adu2339↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cance… DOI 10.1038/s43018-021-00258-w↗
- Uday Kishore · 3 shared papers, 2021–2025 · strength 0.43
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper Neutrophil-derived complement factor P induces cytotoxicity in basal-like cells via caspase 3/7 activation in pancreati… DOI 10.1101/2023.10.28.564512↗
- Paper TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cance… DOI 10.1038/s43018-021-00258-w↗
- Mengyu Tu · 3 shared papers, 2021–2025 · strength 0.43
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper Neutrophil-derived complement factor P induces cytotoxicity in basal-like cells via caspase 3/7 activation in pancreati… DOI 10.1101/2023.10.28.564512↗
- Paper TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cance… DOI 10.1038/s43018-021-00258-w↗
- Rebecca Diya Samuel · 2 shared papers, 2025 · strength 0.40
- Paper TP53 missense-specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer. DOI 10.1126/sciadv.adu2339↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Argyris Papantonis · 2 shared papers, 2021–2025 · strength 0.28
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cance… DOI 10.1038/s43018-021-00258-w↗
- Elisa Espinet Espinet · 2 shared papers, 2021–2025 · strength 0.28
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cance… DOI 10.1038/s43018-021-00258-w↗
- Andreas Trumpp · 2 shared papers, 2021–2025 · strength 0.28
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cance… DOI 10.1038/s43018-021-00258-w↗
- Michael B. Ghadimi · 1 shared paper, 2025 · strength 0.22
- Ramona Schulz‐Heddergott · 1 shared paper, 2025 · strength 0.22
- Ulrich Sax · 1 shared paper, 2025 · strength 0.22
- Nelson Dusetti · 1 shared paper, 2025 · strength 0.22
- Rama Khokha · 1 shared paper, 2025 · strength 0.18
- Muhammad Umair Latif · 1 shared paper, 2025 · strength 0.18
- Barbara T. Grünwald · 1 shared paper, 2025 · strength 0.18
- Kazeera Aliar · 1 shared paper, 2025 · strength 0.18
- Niklas Krebs · 1 shared paper, 2025 · strength 0.18
- Albrecht Neeße · 2 shared papers, 2020–2021 · strength 0.18
- Paper TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cance… DOI 10.1038/s43018-021-00258-w↗
- Paper EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of GATA6. DOI 10.1158/0008-5472.can-20-0672↗
- Rémy Nicolle · 1 shared paper, 2023 · strength 0.15
- Susanne Roth · 1 shared paper, 2023 · strength 0.15
- Adi Danieli‐Mackay · 1 shared paper, 2021 · strength 0.10
- Stephan A. Hahn · 1 shared paper, 2021 · strength 0.10
- Xin Wang · 1 shared paper, 2020 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.